DBI vs ZUMZ

DBI exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and operational deterioration. While the stock has seen a massive 1-year price surge of 203.8%, this rally is decoupled from fundamentals: revenue growth is stagnant at 0.00%, and the company is operating with negative profit and operating margins. A critical Debt/Equity ratio of 4.30 and a dangerously low Quick Ratio of 0.19 suggest significant liquidity risks. Furthermore, the dividend is unsustainable with a 500% payout ratio, effectively acting as a return of capital rather than a return on earnings.

ZUMZ exhibits strong financial health with a Piotroski F-Score of 7/9, indicating a robust operational recovery. While earnings growth is impressive at 49.1% YoY and the PEG ratio of 0.96 suggests reasonable valuation relative to growth, the current price of $24.64 trades at a premium to both the Graham Number ($19.3) and the Intrinsic Value ($23.01). The outlook is tempered by extremely thin net profit margins (1.44%) and a bearish insider sentiment characterized by consistent selling.